Citeline Podcasts

Pan-cancer screening test developer Grail bags more than $1bn in funding; Trump bashes US FDA; fight likely in Senate over Seema Verma's appointment to head CMS; "FDA Precheck" floated by agency; a deep-dive look into the surgical robot market.

Pan-cancer screening test developer Grail bags more than $1bn in funding; Trump bashes US FDA; fight likely in Senate over Seema Verma's appointment to head CMS; "FDA Precheck" floated by agency; a deep-dive look into the surgical robot market.

This is Compliance 360°, an eight-part podcast series from Medtech Insight on US FDA compliance and enforcement issues. In this fourth installment, former FDA investigations branch director Ricki Chase explains how your firm can better manage your quality data.

This is Compliance 360°, an eight-part podcast series from Medtech Insight on US FDA compliance and enforcement issues. In this fourth installment, former FDA investigations branch director Ricki Chase explains how your firm can better manage your quality data.

This is Compliance 360°, an eight-part podcast series from Medtech Insight on US FDA compliance and enforcement issues. In this fourth installment, former FDA investigations branch director Ricki Chase explains how your firm can better manage your quality data.

Brexit will dominate the thoughts, behavior and business of medical technology companies in the UK for many years to come.

The hard work for the UK govt is yet to come, given the EU withdrawal talks and the trading relationship negotiations that the UK has yet to embark on with the EU.

The local industry is stressing any positives, including development of the govt’s new Life Sciences Strategy, part of the overall UK Industrial Strategy. This should offer manufacturers much support.

In this podcast, Association of British Healthcare Industries' (ABHI) chief operating officer Nishan Sunthares, and director of healthcare policy Richard Phillips, set the scene for Brexit, describe the current realities and air their thoughts about the potential opportunities that could emerge from a situation that few had thought likely.

Brexit will dominate the thoughts, behavior and business of medical technology companies in the UK for many years to come.

The hard work for the UK govt is yet to come, given the EU withdrawal talks and the trading relationship negotiations that the UK has yet to embark on with the EU.

The local industry is stressing any positives, including development of the govt’s new Life Sciences Strategy, part of the overall UK Industrial Strategy. This should offer manufacturers much support.

In this podcast, Association of British Healthcare Industries' (ABHI) chief operating officer Nishan Sunthares, and director of healthcare policy Richard Phillips, set the scene for Brexit, describe the current realities and air their thoughts about the potential opportunities that could emerge from a situation that few had thought likely.

Brexit will dominate the thoughts, behavior and business of medical technology companies in the UK for many years to come.

The hard work for the UK govt is yet to come, given the EU withdrawal talks and the trading relationship negotiations that the UK has yet to embark on with the EU.

The local industry is stressing any positives, including development of the govt’s new Life Sciences Strategy, part of the overall UK Industrial Strategy. This should offer manufacturers much support.

In this podcast, Association of British Healthcare Industries' (ABHI) chief operating officer Nishan Sunthares, and director of healthcare policy Richard Phillips, set the scene for Brexit, describe the current realities and air their thoughts about the potential opportunities that could emerge from a situation that few had thought likely.

Attorney Alexis Ronickher speaks with Medtech Insight about what protections cybersecurity whistleblowers may have in the medical device industry.

Attorney Alexis Ronickher speaks with Medtech Insight about what protections cybersecurity whistleblowers may have in the medical device industry.